| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthritis, Rheumatoid | 140 | 2022 | 3763 | 11.360 |
Why?
|
| Lupus Erythematosus, Systemic | 56 | 2022 | 2155 | 3.790 |
Why?
|
| Smoking | 39 | 2021 | 9053 | 2.310 |
Why?
|
| Peptides, Cyclic | 20 | 2017 | 392 | 2.050 |
Why?
|
| Autoantibodies | 27 | 2021 | 2118 | 1.740 |
Why?
|
| Nurses | 28 | 2021 | 2478 | 1.490 |
Why?
|
| Electronic Health Records | 29 | 2022 | 4811 | 1.310 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 8 | 2019 | 64 | 1.160 |
Why?
|
| Genetic Predisposition to Disease | 42 | 2022 | 17904 | 1.150 |
Why?
|
| Risk Factors | 130 | 2022 | 74213 | 1.090 |
Why?
|
| Health Behavior | 7 | 2022 | 2644 | 0.950 |
Why?
|
| Rheumatoid Factor | 13 | 2019 | 185 | 0.910 |
Why?
|
| Middle Aged | 198 | 2022 | 220921 | 0.890 |
Why?
|
| Prospective Studies | 74 | 2023 | 54423 | 0.860 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 4 | 2023 | 3204 | 0.860 |
Why?
|
| Sleep Apnea Syndromes | 2 | 2021 | 975 | 0.820 |
Why?
|
| Adult | 179 | 2022 | 221210 | 0.810 |
Why?
|
| Case-Control Studies | 51 | 2021 | 22176 | 0.800 |
Why?
|
| HLA-DR Antigens | 6 | 2018 | 602 | 0.790 |
Why?
|
| Alcohol Drinking | 14 | 2020 | 4028 | 0.780 |
Why?
|
| Vitamin D | 10 | 2015 | 3303 | 0.780 |
Why?
|
| Female | 228 | 2022 | 392705 | 0.750 |
Why?
|
| Connective Tissue Diseases | 8 | 2020 | 285 | 0.740 |
Why?
|
| C-Reactive Protein | 10 | 2015 | 3826 | 0.720 |
Why?
|
| Antirheumatic Agents | 14 | 2020 | 1373 | 0.690 |
Why?
|
| Polymorphism, Single Nucleotide | 25 | 2022 | 15936 | 0.680 |
Why?
|
| Antibodies, Antinuclear | 8 | 2021 | 343 | 0.670 |
Why?
|
| Incidence | 44 | 2022 | 21355 | 0.660 |
Why?
|
| Humans | 280 | 2023 | 761596 | 0.660 |
Why?
|
| Adolescent Development | 2 | 2013 | 282 | 0.660 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2023 | 311 | 0.660 |
Why?
|
| Proportional Hazards Models | 32 | 2020 | 12463 | 0.640 |
Why?
|
| Natural Language Processing | 9 | 2019 | 1163 | 0.590 |
Why?
|
| Breast Implants | 6 | 2001 | 411 | 0.580 |
Why?
|
| Environment | 4 | 2014 | 1123 | 0.570 |
Why?
|
| Cohort Studies | 61 | 2021 | 41495 | 0.550 |
Why?
|
| Glutathione Transferase | 2 | 2010 | 565 | 0.550 |
Why?
|
| Antioxidants | 3 | 2010 | 1668 | 0.540 |
Why?
|
| Arthritis, Psoriatic | 3 | 2017 | 219 | 0.530 |
Why?
|
| Environmental Exposure | 9 | 2018 | 4485 | 0.520 |
Why?
|
| Postmenopause | 3 | 2017 | 2513 | 0.520 |
Why?
|
| Methotrexate | 7 | 2020 | 1719 | 0.520 |
Why?
|
| Seafood | 2 | 2019 | 393 | 0.520 |
Why?
|
| Smoking Cessation | 4 | 2019 | 2057 | 0.500 |
Why?
|
| Rheumatic Fever | 1 | 2015 | 73 | 0.500 |
Why?
|
| TNF Receptor-Associated Factor 1 | 1 | 2015 | 48 | 0.500 |
Why?
|
| Algorithms | 17 | 2021 | 14033 | 0.490 |
Why?
|
| HLA Antigens | 3 | 2020 | 1328 | 0.490 |
Why?
|
| Inflammatory Bowel Diseases | 12 | 2019 | 2422 | 0.490 |
Why?
|
| Alleles | 19 | 2021 | 6864 | 0.490 |
Why?
|
| Breast Feeding | 5 | 2017 | 1360 | 0.490 |
Why?
|
| Biological Specimen Banks | 6 | 2022 | 783 | 0.480 |
Why?
|
| Asthma | 8 | 2022 | 6234 | 0.480 |
Why?
|
| Feeding Behavior | 6 | 2021 | 3188 | 0.480 |
Why?
|
| Tumor Necrosis Factor-alpha | 10 | 2019 | 4352 | 0.480 |
Why?
|
| Genes, MHC Class II | 1 | 2015 | 434 | 0.470 |
Why?
|
| Family | 2 | 2016 | 3195 | 0.470 |
Why?
|
| Genetic Variation | 10 | 2021 | 6567 | 0.460 |
Why?
|
| United States | 51 | 2021 | 72340 | 0.460 |
Why?
|
| Multivariate Analysis | 28 | 2018 | 12059 | 0.450 |
Why?
|
| Amino Acids | 2 | 2021 | 1718 | 0.450 |
Why?
|
| Aged | 82 | 2021 | 169310 | 0.430 |
Why?
|
| Patient Education as Topic | 4 | 2018 | 2319 | 0.430 |
Why?
|
| Colitis, Ulcerative | 8 | 2019 | 1922 | 0.410 |
Why?
|
| Risk Assessment | 29 | 2021 | 23996 | 0.410 |
Why?
|
| Military Personnel | 2 | 2021 | 1246 | 0.410 |
Why?
|
| Sulfur Dioxide | 1 | 2012 | 178 | 0.400 |
Why?
|
| Crohn Disease | 8 | 2019 | 2279 | 0.400 |
Why?
|
| Arthritis | 2 | 2016 | 680 | 0.400 |
Why?
|
| Genome-Wide Association Study | 19 | 2022 | 12690 | 0.400 |
Why?
|
| Women's Health | 8 | 2021 | 2065 | 0.400 |
Why?
|
| Severity of Illness Index | 18 | 2021 | 15843 | 0.390 |
Why?
|
| Pneumonia | 3 | 2021 | 2143 | 0.390 |
Why?
|
| Autoimmunity | 3 | 2015 | 1356 | 0.380 |
Why?
|
| Pain Threshold | 2 | 2013 | 604 | 0.380 |
Why?
|
| Male | 121 | 2022 | 360846 | 0.380 |
Why?
|
| Hazardous Substances | 1 | 2012 | 153 | 0.370 |
Why?
|
| Particulate Matter | 2 | 2013 | 2605 | 0.370 |
Why?
|
| Silicon Dioxide | 2 | 2015 | 216 | 0.360 |
Why?
|
| Obesity, Morbid | 1 | 2021 | 1277 | 0.360 |
Why?
|
| Silicones | 3 | 2001 | 228 | 0.350 |
Why?
|
| Interleukin-6 | 3 | 2012 | 3208 | 0.350 |
Why?
|
| Life Style | 8 | 2021 | 3917 | 0.350 |
Why?
|
| Hydrolases | 2 | 2008 | 147 | 0.350 |
Why?
|
| Age Factors | 15 | 2020 | 18399 | 0.350 |
Why?
|
| Antibodies, Anti-Idiotypic | 2 | 2010 | 357 | 0.340 |
Why?
|
| Odds Ratio | 16 | 2019 | 9647 | 0.340 |
Why?
|
| Diet | 7 | 2019 | 8075 | 0.340 |
Why?
|
| Genotype | 17 | 2021 | 12990 | 0.340 |
Why?
|
| Obesity | 10 | 2022 | 12947 | 0.340 |
Why?
|
| Body Mass Index | 18 | 2022 | 12953 | 0.340 |
Why?
|
| Health Surveys | 9 | 2019 | 4061 | 0.340 |
Why?
|
| Meat | 3 | 2009 | 584 | 0.330 |
Why?
|
| Sweden | 10 | 2017 | 1379 | 0.330 |
Why?
|
| Nucleotide Deaminases | 1 | 2009 | 11 | 0.330 |
Why?
|
| Nitrogen Dioxide | 1 | 2012 | 522 | 0.330 |
Why?
|
| Hydroxymethyl and Formyl Transferases | 1 | 2009 | 18 | 0.330 |
Why?
|
| Menopause | 1 | 2017 | 1646 | 0.330 |
Why?
|
| Lipoproteins | 1 | 2013 | 881 | 0.320 |
Why?
|
| Urban Population | 3 | 2018 | 2036 | 0.310 |
Why?
|
| Genetic Association Studies | 2 | 2015 | 2735 | 0.310 |
Why?
|
| Birth Weight | 4 | 2009 | 2103 | 0.310 |
Why?
|
| Medical Records | 4 | 2021 | 1408 | 0.310 |
Why?
|
| Heme Oxygenase-1 | 1 | 2010 | 366 | 0.300 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 2 | 2012 | 344 | 0.300 |
Why?
|
| Time Factors | 26 | 2021 | 39969 | 0.300 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2021 | 1875 | 0.300 |
Why?
|
| Geography | 1 | 2010 | 656 | 0.290 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2023 | 12149 | 0.290 |
Why?
|
| Polymorphism, Genetic | 5 | 2010 | 4243 | 0.290 |
Why?
|
| Fibromyalgia | 2 | 2009 | 405 | 0.290 |
Why?
|
| Hospitalization | 6 | 2022 | 10721 | 0.290 |
Why?
|
| Transportation | 1 | 2009 | 217 | 0.280 |
Why?
|
| Hazardous Waste | 1 | 2007 | 24 | 0.280 |
Why?
|
| Lipids | 2 | 2019 | 3341 | 0.280 |
Why?
|
| Prolactin | 1 | 2009 | 625 | 0.280 |
Why?
|
| Contraceptives, Oral | 4 | 2017 | 554 | 0.280 |
Why?
|
| Body Weight | 1 | 2017 | 4618 | 0.280 |
Why?
|
| ROC Curve | 8 | 2021 | 3578 | 0.280 |
Why?
|
| Air Pollution | 2 | 2012 | 2359 | 0.280 |
Why?
|
| Logistic Models | 16 | 2020 | 13255 | 0.270 |
Why?
|
| Overweight | 2 | 2014 | 2417 | 0.270 |
Why?
|
| Iron, Dietary | 1 | 2007 | 148 | 0.260 |
Why?
|
| Pravastatin | 2 | 2007 | 392 | 0.260 |
Why?
|
| Estrogen Replacement Therapy | 5 | 2015 | 1208 | 0.250 |
Why?
|
| Solvents | 1 | 2006 | 295 | 0.250 |
Why?
|
| Demography | 2 | 2010 | 1648 | 0.250 |
Why?
|
| Multienzyme Complexes | 1 | 2009 | 666 | 0.250 |
Why?
|
| Rheumatic Diseases | 3 | 2020 | 649 | 0.250 |
Why?
|
| Reproductive History | 2 | 2013 | 211 | 0.240 |
Why?
|
| Cardiovascular Diseases | 10 | 2020 | 15502 | 0.240 |
Why?
|
| Antigens, CD | 4 | 2013 | 4001 | 0.240 |
Why?
|
| Rheumatology | 4 | 2020 | 615 | 0.240 |
Why?
|
| Pregnancy Complications | 4 | 2019 | 2947 | 0.230 |
Why?
|
| Vitamin E | 1 | 2008 | 872 | 0.230 |
Why?
|
| Dietary Proteins | 2 | 2007 | 952 | 0.230 |
Why?
|
| Prevalence | 14 | 2021 | 15733 | 0.230 |
Why?
|
| Antibodies | 2 | 2009 | 2418 | 0.230 |
Why?
|
| Epstein-Barr Virus Infections | 2 | 2011 | 612 | 0.230 |
Why?
|
| Depressive Disorder, Major | 2 | 2021 | 4762 | 0.230 |
Why?
|
| Complement C4 | 2 | 2021 | 217 | 0.230 |
Why?
|
| Risk Reduction Behavior | 3 | 2021 | 1112 | 0.220 |
Why?
|
| Sex Factors | 9 | 2020 | 10554 | 0.220 |
Why?
|
| Menarche | 3 | 2017 | 532 | 0.220 |
Why?
|
| Phenotype | 12 | 2019 | 16592 | 0.220 |
Why?
|
| Area Under Curve | 4 | 2021 | 1638 | 0.220 |
Why?
|
| Social Class | 4 | 2009 | 2004 | 0.210 |
Why?
|
| Diet, Mediterranean | 3 | 2021 | 740 | 0.210 |
Why?
|
| Psoriasis | 3 | 2017 | 950 | 0.210 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3086 | 0.210 |
Why?
|
| Hypercholesterolemia | 2 | 2007 | 1141 | 0.210 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3206 | 0.210 |
Why?
|
| Pain | 3 | 2021 | 5073 | 0.210 |
Why?
|
| Bronchial Spasm | 1 | 2022 | 71 | 0.210 |
Why?
|
| Follow-Up Studies | 23 | 2020 | 39106 | 0.200 |
Why?
|
| Age of Onset | 5 | 2021 | 3306 | 0.200 |
Why?
|
| Complement C3 | 2 | 2021 | 435 | 0.200 |
Why?
|
| Reproduction | 1 | 2007 | 645 | 0.200 |
Why?
|
| Risk | 13 | 2021 | 9610 | 0.200 |
Why?
|
| Sensitivity and Specificity | 14 | 2022 | 14665 | 0.200 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2018 | 3246 | 0.200 |
Why?
|
| Estrogens | 2 | 2007 | 1522 | 0.200 |
Why?
|
| Inflammation | 3 | 2012 | 10774 | 0.200 |
Why?
|
| Sulfonylurea Compounds | 1 | 2023 | 219 | 0.200 |
Why?
|
| Arteriosclerosis | 2 | 2005 | 1055 | 0.200 |
Why?
|
| Parity | 3 | 2015 | 927 | 0.200 |
Why?
|
| Androgens | 1 | 2009 | 1286 | 0.190 |
Why?
|
| Dairy Products | 2 | 2021 | 490 | 0.190 |
Why?
|
| Practice Guidelines as Topic | 2 | 2020 | 7391 | 0.190 |
Why?
|
| Uterine Cervical Dysplasia | 2 | 2016 | 384 | 0.190 |
Why?
|
| Epitopes | 4 | 2016 | 2503 | 0.190 |
Why?
|
| Silicone Gels | 1 | 2001 | 39 | 0.190 |
Why?
|
| Models, Genetic | 4 | 2015 | 3442 | 0.190 |
Why?
|
| Xenobiotics | 1 | 2021 | 70 | 0.180 |
Why?
|
| Nuts | 2 | 2021 | 264 | 0.180 |
Why?
|
| Immunoglobulin G | 9 | 2022 | 4544 | 0.180 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2021 | 819 | 0.180 |
Why?
|
| Socioeconomic Factors | 5 | 2014 | 7828 | 0.180 |
Why?
|
| Multiple Sclerosis | 3 | 2013 | 3222 | 0.180 |
Why?
|
| Research Design | 3 | 2017 | 6180 | 0.180 |
Why?
|
| Cross-Sectional Studies | 12 | 2022 | 26129 | 0.180 |
Why?
|
| Population Surveillance | 2 | 2005 | 2598 | 0.170 |
Why?
|
| Vitamin D Deficiency | 3 | 2014 | 1388 | 0.170 |
Why?
|
| Heart Injuries | 1 | 2021 | 206 | 0.170 |
Why?
|
| Carotenoids | 2 | 2017 | 621 | 0.170 |
Why?
|
| Hypersensitivity, Immediate | 1 | 2022 | 347 | 0.170 |
Why?
|
| Suicide, Attempted | 2 | 2019 | 1402 | 0.170 |
Why?
|
| Chi-Square Distribution | 4 | 2014 | 3415 | 0.170 |
Why?
|
| Receptors, Tumor Necrosis Factor | 4 | 2013 | 585 | 0.170 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2018 | 4016 | 0.160 |
Why?
|
| Attitude to Health | 3 | 2007 | 2025 | 0.160 |
Why?
|
| Air Pollutants | 1 | 2013 | 2896 | 0.160 |
Why?
|
| Citrulline | 2 | 2016 | 106 | 0.160 |
Why?
|
| Metabolome | 3 | 2020 | 989 | 0.160 |
Why?
|
| Coffee | 1 | 2003 | 593 | 0.160 |
Why?
|
| Premature Birth | 2 | 2018 | 1782 | 0.160 |
Why?
|
| Obesity, Abdominal | 2 | 2020 | 374 | 0.160 |
Why?
|
| Adolescent | 24 | 2022 | 88326 | 0.160 |
Why?
|
| Vital Capacity | 1 | 2021 | 971 | 0.160 |
Why?
|
| Dyslipidemias | 2 | 2018 | 868 | 0.160 |
Why?
|
| Haplotypes | 3 | 2018 | 2713 | 0.160 |
Why?
|
| Suicidal Ideation | 2 | 2019 | 1447 | 0.160 |
Why?
|
| Osteoarthritis, Hip | 1 | 2003 | 409 | 0.160 |
Why?
|
| Milk | 1 | 2021 | 443 | 0.150 |
Why?
|
| Paraproteinemias | 1 | 2001 | 248 | 0.150 |
Why?
|
| Young Adult | 24 | 2021 | 59260 | 0.150 |
Why?
|
| Nutritive Value | 1 | 2021 | 350 | 0.150 |
Why?
|
| Occupational Diseases | 1 | 2006 | 1490 | 0.150 |
Why?
|
| Coronary Disease | 3 | 2018 | 5914 | 0.150 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2016 | 4575 | 0.150 |
Why?
|
| Cesarean Section | 2 | 2018 | 1398 | 0.140 |
Why?
|
| Genetic Loci | 4 | 2021 | 2632 | 0.140 |
Why?
|
| Genetic Testing | 3 | 2021 | 3537 | 0.140 |
Why?
|
| Educational Status | 3 | 2015 | 2522 | 0.140 |
Why?
|
| Antibodies, Viral | 4 | 2022 | 3156 | 0.140 |
Why?
|
| Labor, Induced | 1 | 2018 | 152 | 0.140 |
Why?
|
| Linear Models | 4 | 2020 | 5872 | 0.140 |
Why?
|
| Aged, 80 and over | 16 | 2021 | 58984 | 0.130 |
Why?
|
| Obstetric Labor Complications | 1 | 2019 | 236 | 0.130 |
Why?
|
| Longitudinal Studies | 9 | 2019 | 14608 | 0.130 |
Why?
|
| Exercise | 4 | 2021 | 5890 | 0.130 |
Why?
|
| Forced Expiratory Volume | 1 | 2021 | 1814 | 0.130 |
Why?
|
| Immune System Diseases | 1 | 1999 | 256 | 0.130 |
Why?
|
| Boston | 8 | 2017 | 9327 | 0.130 |
Why?
|
| Disease | 1 | 2021 | 672 | 0.130 |
Why?
|
| Cyclooxygenase 2 | 1 | 2018 | 597 | 0.130 |
Why?
|
| Databases, Factual | 5 | 2021 | 7968 | 0.130 |
Why?
|
| Herpes Zoster | 1 | 2018 | 253 | 0.130 |
Why?
|
| Chemokines | 1 | 2020 | 959 | 0.130 |
Why?
|
| Hypoglycemic Agents | 3 | 2023 | 3085 | 0.130 |
Why?
|
| Pesticides | 1 | 2018 | 296 | 0.130 |
Why?
|
| Joint Prosthesis | 1 | 1997 | 253 | 0.130 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2015 | 121 | 0.130 |
Why?
|
| TYK2 Kinase | 1 | 2015 | 38 | 0.120 |
Why?
|
| Weight Gain | 3 | 2022 | 2348 | 0.120 |
Why?
|
| Molecular Targeted Therapy | 2 | 2019 | 2811 | 0.120 |
Why?
|
| Health Education | 2 | 2018 | 1052 | 0.120 |
Why?
|
| Multifactorial Inheritance | 2 | 2020 | 1387 | 0.120 |
Why?
|
| Central Nervous System Stimulants | 1 | 2003 | 1177 | 0.120 |
Why?
|
| Arginine | 1 | 2018 | 934 | 0.120 |
Why?
|
| Osteoarthritis | 3 | 2018 | 1063 | 0.120 |
Why?
|
| Hypertension | 4 | 2021 | 8540 | 0.120 |
Why?
|
| International Classification of Diseases | 2 | 2018 | 910 | 0.120 |
Why?
|
| Causality | 1 | 2021 | 1242 | 0.120 |
Why?
|
| Retrospective Studies | 19 | 2023 | 80647 | 0.120 |
Why?
|
| Colorectal Neoplasms | 4 | 2016 | 6938 | 0.120 |
Why?
|
| Autoimmune Diseases | 2 | 2009 | 2244 | 0.120 |
Why?
|
| Disease Progression | 8 | 2019 | 13510 | 0.120 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2018 | 4369 | 0.120 |
Why?
|
| Antibodies, Monoclonal | 5 | 2015 | 9177 | 0.120 |
Why?
|
| HLA-DR3 Antigen | 1 | 2014 | 24 | 0.120 |
Why?
|
| HLA-B Antigens | 1 | 2015 | 317 | 0.120 |
Why?
|
| Stiff-Person Syndrome | 1 | 1994 | 31 | 0.110 |
Why?
|
| Gastrointestinal Agents | 2 | 2016 | 510 | 0.110 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 934 | 0.110 |
Why?
|
| Minority Groups | 1 | 2021 | 1203 | 0.110 |
Why?
|
| Lipoprotein(a) | 1 | 2018 | 480 | 0.110 |
Why?
|
| Genetic Pleiotropy | 1 | 2015 | 181 | 0.110 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2019 | 1802 | 0.110 |
Why?
|
| Antigens, Differentiation | 2 | 2007 | 909 | 0.110 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 2013 | 71 | 0.110 |
Why?
|
| Pregnancy | 10 | 2019 | 29890 | 0.110 |
Why?
|
| Hypersensitivity | 1 | 2022 | 1171 | 0.110 |
Why?
|
| Psychotic Disorders | 2 | 2019 | 3223 | 0.110 |
Why?
|
| Aminolevulinic Acid | 1 | 2014 | 144 | 0.110 |
Why?
|
| Carbonated Beverages | 1 | 2014 | 210 | 0.110 |
Why?
|
| Registries | 3 | 2018 | 8225 | 0.110 |
Why?
|
| Gout | 3 | 2005 | 621 | 0.110 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2016 | 2020 | 0.110 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2022 | 1881 | 0.110 |
Why?
|
| Immunologic Factors | 3 | 2015 | 1590 | 0.110 |
Why?
|
| Blood Sedimentation | 1 | 2014 | 235 | 0.100 |
Why?
|
| Atherosclerosis | 3 | 2017 | 3407 | 0.100 |
Why?
|
| Chemokine CCL2 | 1 | 2015 | 605 | 0.100 |
Why?
|
| Coronary Artery Disease | 3 | 2020 | 6403 | 0.100 |
Why?
|
| Communicable Diseases | 1 | 2021 | 875 | 0.100 |
Why?
|
| Double-Blind Method | 5 | 2020 | 12341 | 0.100 |
Why?
|
| Predictive Value of Tests | 6 | 2009 | 15266 | 0.100 |
Why?
|
| Gases | 1 | 2013 | 204 | 0.100 |
Why?
|
| Genome, Human | 4 | 2021 | 4425 | 0.100 |
Why?
|
| Dietary Sucrose | 1 | 2014 | 243 | 0.100 |
Why?
|
| Chromosomes, Human | 2 | 2018 | 441 | 0.100 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2003 | 1413 | 0.100 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2013 | 161 | 0.100 |
Why?
|
| Carotid Artery Diseases | 1 | 2018 | 877 | 0.100 |
Why?
|
| GPI-Linked Proteins | 1 | 2014 | 470 | 0.100 |
Why?
|
| Lipid Metabolism | 1 | 2020 | 1902 | 0.100 |
Why?
|
| Sex Distribution | 1 | 1997 | 2280 | 0.100 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2014 | 177 | 0.100 |
Why?
|
| Anxiety Disorders | 2 | 2013 | 2720 | 0.090 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2017 | 974 | 0.090 |
Why?
|
| Immunoglobulin A | 3 | 2021 | 978 | 0.090 |
Why?
|
| Metabolomics | 1 | 2020 | 1659 | 0.090 |
Why?
|
| Sjogren's Syndrome | 1 | 2013 | 238 | 0.090 |
Why?
|
| Prognosis | 9 | 2021 | 29629 | 0.090 |
Why?
|
| Gene Frequency | 3 | 2018 | 3606 | 0.090 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2019 | 918 | 0.090 |
Why?
|
| Respiratory Tract Diseases | 1 | 2016 | 750 | 0.090 |
Why?
|
| Parturition | 1 | 2014 | 448 | 0.090 |
Why?
|
| Vitamins | 2 | 2010 | 1635 | 0.090 |
Why?
|
| Health Fairs | 1 | 2009 | 2 | 0.090 |
Why?
|
| Survival Rate | 3 | 2020 | 12723 | 0.090 |
Why?
|
| Epidemiologic Studies | 2 | 2021 | 675 | 0.090 |
Why?
|
| Immunoglobulin M | 3 | 2021 | 1526 | 0.090 |
Why?
|
| Lipoproteins, LDL | 1 | 2013 | 642 | 0.090 |
Why?
|
| Depressive Disorder | 2 | 2013 | 3728 | 0.090 |
Why?
|
| Seroepidemiologic Studies | 3 | 2013 | 397 | 0.090 |
Why?
|
| Data Interpretation, Statistical | 2 | 2019 | 2691 | 0.090 |
Why?
|
| Models, Statistical | 3 | 2015 | 5079 | 0.080 |
Why?
|
| Cytokines | 3 | 2020 | 7396 | 0.080 |
Why?
|
| Motivation | 2 | 2018 | 2006 | 0.080 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2016 | 1844 | 0.080 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 1994 | 664 | 0.080 |
Why?
|
| Anthropometry | 1 | 2014 | 1349 | 0.080 |
Why?
|
| Telomere | 1 | 2016 | 943 | 0.080 |
Why?
|
| Disease Management | 1 | 2020 | 2508 | 0.080 |
Why?
|
| Occupational Health | 1 | 2016 | 806 | 0.080 |
Why?
|
| Fatigue | 2 | 2009 | 1552 | 0.080 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 2630 | 0.080 |
Why?
|
| Translations | 2 | 2019 | 81 | 0.080 |
Why?
|
| Immunosuppressive Agents | 2 | 2014 | 4176 | 0.080 |
Why?
|
| Decision Making | 2 | 2007 | 3929 | 0.080 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2012 | 294 | 0.080 |
Why?
|
| Particle Size | 1 | 2013 | 1648 | 0.080 |
Why?
|
| Reproducibility of Results | 10 | 2021 | 20100 | 0.080 |
Why?
|
| Morbidity | 1 | 2014 | 1752 | 0.080 |
Why?
|
| Genomics | 2 | 2021 | 5821 | 0.080 |
Why?
|
| Oral Health | 1 | 2014 | 492 | 0.080 |
Why?
|
| Linkage Disequilibrium | 1 | 2014 | 1998 | 0.080 |
Why?
|
| Databases, Genetic | 3 | 2021 | 1742 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 2273 | 0.080 |
Why?
|
| Proteome | 1 | 2018 | 1862 | 0.080 |
Why?
|
| Dietary Supplements | 2 | 2012 | 3415 | 0.080 |
Why?
|
| Health | 1 | 2011 | 398 | 0.080 |
Why?
|
| Synovitis | 1 | 2009 | 217 | 0.080 |
Why?
|
| Survival Analysis | 2 | 2017 | 10090 | 0.080 |
Why?
|
| Diet Surveys | 3 | 2021 | 1162 | 0.080 |
Why?
|
| Delayed Diagnosis | 1 | 2012 | 463 | 0.070 |
Why?
|
| Health Status | 6 | 2013 | 4077 | 0.070 |
Why?
|
| Hypothyroidism | 1 | 2013 | 668 | 0.070 |
Why?
|
| Epidemiologic Methods | 2 | 2010 | 1336 | 0.070 |
Why?
|
| Critical Care | 1 | 2020 | 2697 | 0.070 |
Why?
|
| Ultraviolet Rays | 1 | 2013 | 1080 | 0.070 |
Why?
|
| Inflammation Mediators | 2 | 2015 | 1886 | 0.070 |
Why?
|
| Diabetes Mellitus | 3 | 2015 | 5841 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2010 | 10766 | 0.070 |
Why?
|
| Genetic Research | 2 | 2021 | 171 | 0.070 |
Why?
|
| Thromboembolism | 1 | 2014 | 995 | 0.070 |
Why?
|
| Massachusetts | 5 | 2018 | 8833 | 0.070 |
Why?
|
| Brachial Artery | 1 | 2009 | 366 | 0.070 |
Why?
|
| Delivery, Obstetric | 1 | 2014 | 941 | 0.070 |
Why?
|
| Sepsis | 1 | 2021 | 2585 | 0.070 |
Why?
|
| Clostridium Infections | 1 | 2014 | 558 | 0.070 |
Why?
|
| Endometriosis | 1 | 2015 | 870 | 0.070 |
Why?
|
| New England | 1 | 2010 | 1054 | 0.070 |
Why?
|
| Treatment Outcome | 13 | 2021 | 64685 | 0.070 |
Why?
|
| Environmental Monitoring | 1 | 2013 | 1460 | 0.070 |
Why?
|
| Periodontal Diseases | 1 | 2010 | 451 | 0.070 |
Why?
|
| Patient Preference | 1 | 2014 | 927 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2007 | 367 | 0.070 |
Why?
|
| Colonoscopy | 1 | 2014 | 1394 | 0.070 |
Why?
|
| Major Histocompatibility Complex | 1 | 2009 | 870 | 0.070 |
Why?
|
| Aging | 2 | 2021 | 8710 | 0.070 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2009 | 2518 | 0.070 |
Why?
|
| Medical Informatics | 1 | 2013 | 733 | 0.070 |
Why?
|
| Herpesvirus 4, Human | 1 | 2011 | 1078 | 0.060 |
Why?
|
| Drug Discovery | 1 | 2013 | 1051 | 0.060 |
Why?
|
| Menopause, Premature | 1 | 2007 | 124 | 0.060 |
Why?
|
| Endpoint Determination | 1 | 2008 | 590 | 0.060 |
Why?
|
| Gene Expression Regulation | 3 | 2019 | 11904 | 0.060 |
Why?
|
| Biomedical Research | 1 | 2021 | 3429 | 0.060 |
Why?
|
| Regional Blood Flow | 1 | 2009 | 1496 | 0.060 |
Why?
|
| Graves Disease | 2 | 2006 | 238 | 0.060 |
Why?
|
| Serologic Tests | 2 | 2019 | 381 | 0.060 |
Why?
|
| Musculoskeletal Diseases | 2 | 2002 | 598 | 0.060 |
Why?
|
| Pain Measurement | 2 | 2013 | 3551 | 0.060 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2006 | 108 | 0.060 |
Why?
|
| Sleep | 1 | 2021 | 4768 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2016 | 1809 | 0.060 |
Why?
|
| Calcinosis | 1 | 2013 | 1469 | 0.060 |
Why?
|
| Vasodilation | 1 | 2009 | 962 | 0.060 |
Why?
|
| Pilot Projects | 4 | 2019 | 8633 | 0.060 |
Why?
|
| GTP-Binding Proteins | 2 | 2022 | 951 | 0.060 |
Why?
|
| Glucocorticoids | 2 | 2019 | 2161 | 0.060 |
Why?
|
| Pandemics | 2 | 2021 | 8656 | 0.060 |
Why?
|
| Genetic Markers | 1 | 2010 | 2601 | 0.060 |
Why?
|
| False Negative Reactions | 1 | 2005 | 573 | 0.060 |
Why?
|
| China | 2 | 2020 | 2374 | 0.060 |
Why?
|
| Repressor Proteins | 2 | 2017 | 2986 | 0.060 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2005 | 457 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2017 | 4758 | 0.050 |
Why?
|
| Menstruation Disturbances | 1 | 2004 | 143 | 0.050 |
Why?
|
| Nutrition Surveys | 1 | 2010 | 1733 | 0.050 |
Why?
|
| Patient Dropouts | 1 | 2005 | 412 | 0.050 |
Why?
|
| Residence Characteristics | 1 | 2013 | 2095 | 0.050 |
Why?
|
| Drinking Behavior | 1 | 2003 | 103 | 0.050 |
Why?
|
| Respiratory Sounds | 2 | 2022 | 702 | 0.050 |
Why?
|
| DNA | 3 | 2021 | 7213 | 0.050 |
Why?
|
| Comorbidity | 5 | 2017 | 10508 | 0.050 |
Why?
|
| Receptors, Androgen | 1 | 2009 | 1079 | 0.050 |
Why?
|
| Drug Synergism | 1 | 2007 | 1757 | 0.050 |
Why?
|
| Self Efficacy | 2 | 2004 | 638 | 0.050 |
Why?
|
| Disclosure | 2 | 2021 | 748 | 0.050 |
Why?
|
| Alcoholic Beverages | 1 | 2004 | 264 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2022 | 3810 | 0.050 |
Why?
|
| Recreation | 1 | 2003 | 125 | 0.050 |
Why?
|
| Treatment Refusal | 1 | 2005 | 429 | 0.050 |
Why?
|
| Duty to Recontact | 1 | 2021 | 19 | 0.050 |
Why?
|
| Receptors, Neuropeptide | 1 | 2022 | 106 | 0.050 |
Why?
|
| Models, Structural | 1 | 2022 | 340 | 0.050 |
Why?
|
| Tea | 1 | 2003 | 288 | 0.050 |
Why?
|
| Diuretics | 1 | 2005 | 610 | 0.050 |
Why?
|
| Cell Degranulation | 1 | 2022 | 277 | 0.050 |
Why?
|
| Remission Induction | 2 | 2019 | 2397 | 0.050 |
Why?
|
| Vitamin B 12 | 1 | 2004 | 524 | 0.050 |
Why?
|
| B-Cell Activating Factor | 1 | 2021 | 115 | 0.050 |
Why?
|
| Quantitative Trait Loci | 1 | 2009 | 2116 | 0.050 |
Why?
|
| Mass Screening | 2 | 2009 | 5429 | 0.050 |
Why?
|
| Clinical Medicine | 1 | 2002 | 145 | 0.050 |
Why?
|
| Societies, Medical | 1 | 2013 | 3905 | 0.050 |
Why?
|
| Data Mining | 2 | 2018 | 551 | 0.050 |
Why?
|
| Fabaceae | 1 | 2021 | 103 | 0.050 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2001 | 106 | 0.050 |
Why?
|
| Putrescine | 1 | 2020 | 42 | 0.050 |
Why?
|
| Butyric Acid | 1 | 2020 | 51 | 0.050 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2001 | 283 | 0.050 |
Why?
|
| Spermidine | 1 | 2020 | 62 | 0.050 |
Why?
|
| Single-Blind Method | 1 | 2004 | 1574 | 0.050 |
Why?
|
| Aspirin | 2 | 2010 | 3133 | 0.040 |
Why?
|
| Purines | 1 | 2004 | 607 | 0.040 |
Why?
|
| Meta-Analysis as Topic | 1 | 2005 | 1380 | 0.040 |
Why?
|
| Phosphatidylethanolamines | 1 | 2020 | 129 | 0.040 |
Why?
|
| Infant, Newborn | 4 | 2021 | 26202 | 0.040 |
Why?
|
| Immunologic Memory | 2 | 2018 | 1359 | 0.040 |
Why?
|
| Caprylates | 1 | 2020 | 115 | 0.040 |
Why?
|
| Asymptomatic Infections | 1 | 2021 | 131 | 0.040 |
Why?
|
| Language | 1 | 2009 | 1543 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2009 | 3415 | 0.040 |
Why?
|
| Depression | 1 | 2019 | 8126 | 0.040 |
Why?
|
| North America | 3 | 2009 | 1276 | 0.040 |
Why?
|
| Digestive System Diseases | 1 | 2021 | 151 | 0.040 |
Why?
|
| Medical Record Linkage | 1 | 2021 | 285 | 0.040 |
Why?
|
| Carnitine | 1 | 2020 | 252 | 0.040 |
Why?
|
| DNA, Single-Stranded | 1 | 2001 | 355 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 5790 | 0.040 |
Why?
|
| Complement Activation | 1 | 2021 | 445 | 0.040 |
Why?
|
| Caffeine | 1 | 2003 | 700 | 0.040 |
Why?
|
| Administration, Inhalation | 1 | 2022 | 1157 | 0.040 |
Why?
|
| Artificial Intelligence | 1 | 2013 | 2578 | 0.040 |
Why?
|
| Cough | 1 | 2022 | 594 | 0.040 |
Why?
|
| Blood Urea Nitrogen | 1 | 2018 | 186 | 0.040 |
Why?
|
| Cyclooxygenase 1 | 1 | 2018 | 97 | 0.040 |
Why?
|
| Infant, Premature | 1 | 2008 | 2107 | 0.040 |
Why?
|
| Vulnerable Populations | 1 | 2004 | 703 | 0.040 |
Why?
|
| Tryptophan | 1 | 2020 | 482 | 0.040 |
Why?
|
| Fetal Distress | 1 | 2018 | 39 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2014 | 4812 | 0.040 |
Why?
|
| Urogenital Abnormalities | 1 | 2021 | 261 | 0.040 |
Why?
|
| Granzymes | 1 | 2019 | 277 | 0.040 |
Why?
|
| Methionine | 1 | 2020 | 572 | 0.040 |
Why?
|
| Diet Records | 1 | 2019 | 427 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2009 | 3701 | 0.040 |
Why?
|
| Neoplasms | 3 | 2014 | 22173 | 0.040 |
Why?
|
| Immunoassay | 1 | 2021 | 745 | 0.040 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2018 | 184 | 0.040 |
Why?
|
| Diabetes Complications | 1 | 2004 | 1315 | 0.040 |
Why?
|
| Mosaicism | 1 | 2021 | 475 | 0.040 |
Why?
|
| Patient Participation | 1 | 2007 | 1445 | 0.040 |
Why?
|
| Cholesterol, LDL | 1 | 2007 | 2382 | 0.040 |
Why?
|
| Macrophage-Activating Factors | 1 | 2017 | 21 | 0.040 |
Why?
|
| Models, Biological | 1 | 2013 | 9469 | 0.040 |
Why?
|
| Lung | 1 | 2016 | 10002 | 0.040 |
Why?
|
| Fetal Macrosomia | 1 | 2018 | 141 | 0.040 |
Why?
|
| Stress, Psychological | 1 | 2012 | 4481 | 0.040 |
Why?
|
| Carrier State | 1 | 2021 | 523 | 0.040 |
Why?
|
| Focus Groups | 2 | 2007 | 1415 | 0.040 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2018 | 137 | 0.030 |
Why?
|
| Self Report | 3 | 2014 | 3725 | 0.030 |
Why?
|
| Chemokine CXCL13 | 1 | 2017 | 59 | 0.030 |
Why?
|
| Abruptio Placentae | 1 | 2018 | 118 | 0.030 |
Why?
|
| Phosphofructokinase-2 | 1 | 2016 | 33 | 0.030 |
Why?
|
| Patient Selection | 2 | 2007 | 4244 | 0.030 |
Why?
|
| Receptors, CXCR5 | 1 | 2017 | 88 | 0.030 |
Why?
|
| Knee Prosthesis | 2 | 1997 | 395 | 0.030 |
Why?
|
| Beer | 1 | 2017 | 134 | 0.030 |
Why?
|
| Fenretinide | 1 | 1996 | 9 | 0.030 |
Why?
|
| Random Allocation | 1 | 2001 | 2395 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2009 | 4431 | 0.030 |
Why?
|
| Role | 1 | 1997 | 176 | 0.030 |
Why?
|
| Troponin T | 1 | 2021 | 780 | 0.030 |
Why?
|
| Interpersonal Relations | 1 | 2004 | 1436 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2021 | 1218 | 0.030 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2018 | 321 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2019 | 999 | 0.030 |
Why?
|
| Waist Circumference | 1 | 2020 | 935 | 0.030 |
Why?
|
| Hair Dyes | 1 | 1996 | 30 | 0.030 |
Why?
|
| Wine | 1 | 2017 | 166 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2017 | 191 | 0.030 |
Why?
|
| Life Change Events | 1 | 2021 | 952 | 0.030 |
Why?
|
| Computer Simulation | 3 | 2015 | 6241 | 0.030 |
Why?
|
| Counseling | 1 | 2004 | 1547 | 0.030 |
Why?
|
| Occupational Exposure | 1 | 2006 | 1813 | 0.030 |
Why?
|
| Hematologic Neoplasms | 2 | 2021 | 1896 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2021 | 1175 | 0.030 |
Why?
|
| Child | 5 | 2021 | 80158 | 0.030 |
Why?
|
| Creatinine | 2 | 2018 | 1899 | 0.030 |
Why?
|
| Collagenases | 1 | 1996 | 222 | 0.030 |
Why?
|
| Cross-Cultural Comparison | 1 | 2019 | 635 | 0.030 |
Why?
|
| Disability Evaluation | 3 | 2010 | 1836 | 0.030 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 621 | 0.030 |
Why?
|
| Placebos | 1 | 2020 | 1667 | 0.030 |
Why?
|
| Lectins, C-Type | 1 | 2018 | 585 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2018 | 945 | 0.030 |
Why?
|
| Mast Cells | 1 | 2022 | 1392 | 0.030 |
Why?
|
| Puerperal Disorders | 1 | 2018 | 300 | 0.030 |
Why?
|
| Informed Consent | 1 | 2021 | 1008 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2022 | 1252 | 0.030 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2020 | 1007 | 0.030 |
Why?
|
| Stillbirth | 1 | 2018 | 368 | 0.030 |
Why?
|
| Immunity | 1 | 2021 | 996 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2018 | 1351 | 0.030 |
Why?
|
| Synovial Fluid | 1 | 2017 | 393 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 2021 | 1768 | 0.030 |
Why?
|
| Placebo Effect | 1 | 2018 | 518 | 0.030 |
Why?
|
| Metalloendopeptidases | 1 | 1996 | 393 | 0.030 |
Why?
|
| Patient Compliance | 1 | 2004 | 2690 | 0.030 |
Why?
|
| Postpartum Hemorrhage | 1 | 2018 | 272 | 0.030 |
Why?
|
| Fetal Growth Retardation | 1 | 2018 | 580 | 0.030 |
Why?
|
| Rectal Fistula | 1 | 2014 | 75 | 0.030 |
Why?
|
| Blood Pressure | 2 | 2020 | 8481 | 0.030 |
Why?
|
| Hematinics | 1 | 2017 | 282 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2010 | 10212 | 0.030 |
Why?
|
| Receptors, Chemokine | 1 | 2017 | 652 | 0.030 |
Why?
|
| Hip Prosthesis | 2 | 1997 | 921 | 0.030 |
Why?
|
| Homozygote | 1 | 2018 | 1776 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2017 | 815 | 0.030 |
Why?
|
| Th1 Cells | 1 | 2018 | 1036 | 0.030 |
Why?
|
| Congenital Abnormalities | 1 | 2018 | 709 | 0.030 |
Why?
|
| Synovial Membrane | 1 | 1996 | 532 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2021 | 42232 | 0.030 |
Why?
|
| Medical Audit | 1 | 2014 | 453 | 0.030 |
Why?
|
| Transaminases | 1 | 1993 | 199 | 0.030 |
Why?
|
| Thyroiditis | 1 | 2013 | 86 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2010 | 10194 | 0.030 |
Why?
|
| Occupations | 1 | 1995 | 515 | 0.030 |
Why?
|
| Age Distribution | 1 | 2018 | 2879 | 0.030 |
Why?
|
| Health Personnel | 3 | 2005 | 3335 | 0.020 |
Why?
|
| Outpatients | 1 | 2020 | 1597 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 2898 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 1995 | 992 | 0.020 |
Why?
|
| Biometry | 1 | 2015 | 563 | 0.020 |
Why?
|
| Interleukins | 1 | 2017 | 782 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2021 | 4125 | 0.020 |
Why?
|
| RNA, Small Cytoplasmic | 1 | 1991 | 19 | 0.020 |
Why?
|
| Education | 1 | 1995 | 537 | 0.020 |
Why?
|
| Regression Analysis | 3 | 2010 | 6345 | 0.020 |
Why?
|
| Republic of Korea | 1 | 2014 | 590 | 0.020 |
Why?
|
| Transglutaminases | 1 | 2013 | 197 | 0.020 |
Why?
|
| Tricuspid Valve Stenosis | 1 | 1991 | 26 | 0.020 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 1991 | 75 | 0.020 |
Why?
|
| Drug Repositioning | 1 | 2013 | 233 | 0.020 |
Why?
|
| Weather | 1 | 2013 | 231 | 0.020 |
Why?
|
| Drug Therapy, Combination | 2 | 2016 | 6312 | 0.020 |
Why?
|
| Postoperative Complications | 2 | 2013 | 15633 | 0.020 |
Why?
|
| Iodide Peroxidase | 1 | 2013 | 294 | 0.020 |
Why?
|
| Thyroiditis, Autoimmune | 1 | 1991 | 101 | 0.020 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2017 | 1192 | 0.020 |
Why?
|
| Skin Diseases | 1 | 2000 | 1094 | 0.020 |
Why?
|
| Social Support | 1 | 2001 | 2172 | 0.020 |
Why?
|
| Academic Medical Centers | 2 | 2017 | 2759 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 1943 | 0.020 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2014 | 506 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2023 | 13446 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2013 | 882 | 0.020 |
Why?
|
| Sample Size | 1 | 2014 | 841 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2018 | 14417 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2015 | 744 | 0.020 |
Why?
|
| Epstein-Barr Virus Nuclear Antigens | 1 | 2011 | 157 | 0.020 |
Why?
|
| Gastrectomy | 1 | 2015 | 672 | 0.020 |
Why?
|
| Myositis | 1 | 1993 | 271 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2015 | 771 | 0.020 |
Why?
|
| Gene Expression | 2 | 2015 | 7581 | 0.020 |
Why?
|
| Maternal Age | 1 | 2013 | 809 | 0.020 |
Why?
|
| Cause of Death | 1 | 2021 | 3683 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2012 | 564 | 0.020 |
Why?
|
| Th17 Cells | 1 | 2016 | 794 | 0.020 |
Why?
|
| Folic Acid | 1 | 2017 | 1323 | 0.020 |
Why?
|
| Portugal | 1 | 2009 | 91 | 0.020 |
Why?
|
| Child Abuse, Sexual | 1 | 2012 | 403 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2022 | 4415 | 0.020 |
Why?
|
| Colorado | 1 | 2009 | 165 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2016 | 1889 | 0.020 |
Why?
|
| Carcinoid Tumor | 1 | 1991 | 224 | 0.020 |
Why?
|
| Information Storage and Retrieval | 1 | 2015 | 819 | 0.020 |
Why?
|
| Hospital Information Systems | 1 | 2012 | 394 | 0.020 |
Why?
|
| Amyloidosis | 1 | 1996 | 817 | 0.020 |
Why?
|
| South America | 1 | 2009 | 179 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 2000 | 1667 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 931 | 0.020 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2014 | 572 | 0.020 |
Why?
|
| Exons | 1 | 2015 | 2391 | 0.020 |
Why?
|
| Kidney Diseases | 1 | 2000 | 2091 | 0.020 |
Why?
|
| Environmental Pollutants | 1 | 2018 | 1277 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2015 | 1601 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2019 | 3025 | 0.020 |
Why?
|
| Tooth Loss | 1 | 2010 | 200 | 0.020 |
Why?
|
| Fear | 1 | 1997 | 1477 | 0.020 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2010 | 224 | 0.020 |
Why?
|
| Spain | 1 | 2009 | 487 | 0.020 |
Why?
|
| Community-Institutional Relations | 1 | 2009 | 206 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2019 | 2922 | 0.020 |
Why?
|
| Joints | 1 | 2009 | 322 | 0.020 |
Why?
|
| Disabled Persons | 1 | 1997 | 1226 | 0.020 |
Why?
|
| Heart Neoplasms | 1 | 1991 | 362 | 0.020 |
Why?
|
| Hypertriglyceridemia | 1 | 2010 | 293 | 0.020 |
Why?
|
| Physical Examination | 1 | 2013 | 1255 | 0.020 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2014 | 874 | 0.020 |
Why?
|
| Gastric Bypass | 1 | 2015 | 818 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2003 | 8002 | 0.020 |
Why?
|
| Renal Dialysis | 1 | 1996 | 1796 | 0.020 |
Why?
|
| Bioprosthesis | 1 | 1991 | 591 | 0.020 |
Why?
|
| Probability | 1 | 2012 | 2477 | 0.020 |
Why?
|
| Europe | 1 | 2013 | 3420 | 0.020 |
Why?
|
| Energy Intake | 1 | 2014 | 2134 | 0.020 |
Why?
|
| Manometry | 1 | 2009 | 454 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2001 | 5799 | 0.020 |
Why?
|
| Postpartum Period | 1 | 2013 | 1175 | 0.020 |
Why?
|
| Income | 1 | 1995 | 1877 | 0.020 |
Why?
|
| Denmark | 1 | 2008 | 771 | 0.020 |
Why?
|
| Information Dissemination | 1 | 2014 | 1126 | 0.020 |
Why?
|
| Bariatric Surgery | 1 | 2015 | 992 | 0.020 |
Why?
|
| Animals | 4 | 2021 | 168475 | 0.020 |
Why?
|
| Biopsy | 1 | 2017 | 6766 | 0.020 |
Why?
|
| Myocardial Infarction | 2 | 2004 | 11461 | 0.020 |
Why?
|
| Stroke | 2 | 2009 | 9758 | 0.020 |
Why?
|
| Ramipril | 1 | 2005 | 102 | 0.020 |
Why?
|
| Altruism | 1 | 2007 | 208 | 0.020 |
Why?
|
| Proteomics | 1 | 2018 | 3848 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 1998 | 7054 | 0.020 |
Why?
|
| Caregivers | 1 | 1997 | 2238 | 0.020 |
Why?
|
| Liver Diseases | 1 | 1993 | 1297 | 0.020 |
Why?
|
| Cell Movement | 1 | 2017 | 5205 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 21019 | 0.010 |
Why?
|
| Early Diagnosis | 1 | 2009 | 1186 | 0.010 |
Why?
|
| Propensity Score | 1 | 2012 | 1913 | 0.010 |
Why?
|
| Physicians | 1 | 2003 | 4591 | 0.010 |
Why?
|
| Communication | 1 | 2018 | 3875 | 0.010 |
Why?
|
| Cholesterol, HDL | 1 | 2010 | 1814 | 0.010 |
Why?
|
| Weight Loss | 1 | 2015 | 2684 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2018 | 5293 | 0.010 |
Why?
|
| Laparoscopy | 1 | 2015 | 2036 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 1998 | 3980 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6484 | 0.010 |
Why?
|
| International Cooperation | 1 | 2010 | 1422 | 0.010 |
Why?
|
| Child Abuse | 1 | 2012 | 1077 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2012 | 6228 | 0.010 |
Why?
|
| Skin | 1 | 2017 | 4484 | 0.010 |
Why?
|
| Review Literature as Topic | 1 | 2005 | 348 | 0.010 |
Why?
|
| Dementia | 1 | 1998 | 2689 | 0.010 |
Why?
|
| Vitamin B Complex | 1 | 2005 | 299 | 0.010 |
Why?
|
| Biological Availability | 1 | 2004 | 390 | 0.010 |
Why?
|
| Kidney | 1 | 2018 | 7048 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2008 | 2341 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2018 | 10451 | 0.010 |
Why?
|
| Insurance, Health | 1 | 1995 | 2499 | 0.010 |
Why?
|
| Primary Prevention | 1 | 2010 | 1186 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 5337 | 0.010 |
Why?
|
| Research | 1 | 2010 | 1982 | 0.010 |
Why?
|
| Computational Biology | 1 | 2013 | 3517 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2009 | 2696 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 1996 | 12794 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 9420 | 0.010 |
Why?
|
| Software | 1 | 2014 | 4434 | 0.010 |
Why?
|
| Patient Readmission | 1 | 2014 | 3271 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2018 | 22174 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 4615 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2012 | 3575 | 0.010 |
Why?
|
| Physician's Role | 1 | 2007 | 917 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2000 | 6845 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2017 | 11530 | 0.010 |
Why?
|
| Mice | 2 | 2018 | 81539 | 0.010 |
Why?
|
| Nutritional Status | 1 | 2007 | 1615 | 0.010 |
Why?
|
| Liver | 1 | 2014 | 7528 | 0.010 |
Why?
|
| Infant | 1 | 2021 | 36193 | 0.010 |
Why?
|
| Vegetables | 1 | 2004 | 1195 | 0.010 |
Why?
|
| Anticholesteremic Agents | 1 | 2005 | 966 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2012 | 9319 | 0.010 |
Why?
|
| Health Services | 1 | 2002 | 752 | 0.010 |
Why?
|
| Prednisone | 1 | 2002 | 1563 | 0.010 |
Why?
|
| Work | 1 | 1997 | 195 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2005 | 2024 | 0.010 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 1996 | 138 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2009 | 5971 | 0.010 |
Why?
|
| beta 2-Microglobulin | 1 | 1996 | 329 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1996 | 1625 | 0.010 |
Why?
|
| Clinical Enzyme Tests | 1 | 1993 | 113 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 1996 | 13642 | 0.010 |
Why?
|
| Laminectomy | 1 | 1994 | 225 | 0.010 |
Why?
|
| Carpal Tunnel Syndrome | 1 | 1996 | 303 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2015 | 23447 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1993 | 411 | 0.010 |
Why?
|
| snRNP Core Proteins | 1 | 1991 | 22 | 0.010 |
Why?
|
| Aspartate Aminotransferases | 1 | 1993 | 416 | 0.010 |
Why?
|
| Cardiolipins | 1 | 1991 | 81 | 0.010 |
Why?
|
| Spinal Stenosis | 1 | 1994 | 261 | 0.010 |
Why?
|
| Alanine Transaminase | 1 | 1993 | 603 | 0.010 |
Why?
|
| Confidence Intervals | 1 | 1995 | 2927 | 0.010 |
Why?
|
| Ribonucleoproteins | 1 | 1991 | 372 | 0.000 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2002 | 3206 | 0.000 |
Why?
|
| Quality of Life | 1 | 2010 | 13367 | 0.000 |
Why?
|
| Psychometrics | 1 | 1998 | 3065 | 0.000 |
Why?
|
| Drug Administration Schedule | 1 | 1996 | 4853 | 0.000 |
Why?
|
| Autoantigens | 1 | 1991 | 891 | 0.000 |
Why?
|
| Activities of Daily Living | 1 | 1996 | 2421 | 0.000 |
Why?
|
| Diagnostic Errors | 1 | 1993 | 1265 | 0.000 |
Why?
|
| Orthopedics | 1 | 1994 | 898 | 0.000 |
Why?
|
| Kidney Failure, Chronic | 1 | 1996 | 2472 | 0.000 |
Why?
|